Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
74,007,590
Share change
+8,497,924
Total reported value
$3,747,901,575
Put/Call ratio
26%
Price per share
$50.64
Number of holders
213
Value change
+$504,714,925
Number of buys
134
Number of sells
78

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q4 2025

As of 31 Dec 2025, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 213 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,007,590 shares. The largest 10 holders included Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., DEERFIELD MANAGEMENT COMPANY, L.P., VANGUARD GROUP INC, Kynam Capital Management, LP, Eversept Partners, LP, FMR LLC, Deep Track Capital, LP, and Sofinnova Investments, Inc.. This page lists 213 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.